ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2021

A Novel Second-Generation EP2 Receptor Antagonist Reduces Neuroinflammation and Gliosis After Status Epilepticus in Rats.

Asheebo Rojas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.